|
|
Legal status
Patent expired
| (51) | INT.CL. | C07D 489/00 | (2006.01) |
| C07D 489/08 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 31/485 | (2006.01) |
| (11) | Number of the document | 2305683 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10011792.8 |
| Date of filing the European patent application | 2005-03-30 | |
| (97) | Date of publication of the European application | 2011-04-06 |
| (45) | Date of publication and mention of the grant of the patent | 2015-01-28 |
| (46) | Date of publication of the claims translation | 2015-05-25 |
| (30) | Number | Date | Country code |
| 557492 P | 2004-03-30 | US | |
| 601534 P | 2004-08-13 | US | |
| 620072 P | 2004-10-18 | US | |
| 648625 P | 2005-01-31 | US | |
| 651778 P | 2005-02-10 | US |
| (72) |
Chapman, Robert, US
Rider, Lonn S., US
Hong, Qi, US
Kyle, Donald, US
Kupper, Robert, US
|
| (73) |
EURO-CELTIQUE S.A.,
1, rue Jean Piret, 2350 Luxembourg,
LU
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Farmacinė vaisto forma, apimanti oksikodoną, turintį mažiau nei 25 ppm 14-hidroksikodeinono |
| Pharmaceutical dosage form comprising oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone |
| Payment date | Validity (years) | Amount | |
| 2024-02-20 | 347.00 EUR |